4David Moher, Kenneth F Schulz, Douglas G Altman, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of paralleo-group randomized trials [J]. TheLancet, 2001; 357(4): 1 191-1 194
5Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF,Stuyt PM, Kastelein JJ. Treatment of primary hypercholesterolaemia.Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study [ J ]. J Intem Med,1993; 234(1): 77-82
6The European Study Group. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia ( multicountry comparative study) [J ]. Am J Cardiol, 1992; 70 ( 15 ): 1281 - 1 286
7Lambrecht LJ, Malini PL. Efficacy and tolerability of simvastatin 20mg vs pravastatin 20 mg in patients with primary hypercholesterolemia.European Study Group[J]. Acta Cardiol, 1993; 48(6): 541 -554
8Steinhagen-Thiessen E. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group [J ].Cardiology, 1994; 85(3-4): 244-254
9The Simvastatin Pravastatin Study Group. Comparison of the efficacy,safety and tolerability of simvastatin and pravastafin for hypercholesterolemia[J]. Am J Cardiol, 1993; 71(16): 1 408-1 414
10The Lovastatin Pravastatin Study Group, A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia[J]. Am J Cardiol, 1993; 71(10): 810 -815
